EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis

Guanjun Zhao, Masmuha Marshed Al Ramadhan, Yifang Zhang

PeerJ · 27.05.2026 · 14 · e21337

DOI: 10.7717/peerj.21337 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PeerJ, online erschienen am 27.05.2026. Verfasst von Guanjun Zhao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University & Sha…. Hauptthemen laut MEDLINE: Monocytes, Uterine Cervical Neoplasms, Lymphocytes. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Systemic inflammatory biomarkers have been associated with outcomes across multiple malignancies, including cervical cancer. The prognostic value of the pretreatment lymphocyte-to-monocyte ratio (LMR) in cervical cancer remains inconsistent across published studies. We therefore performed a systematic review and meta-analysis to clarify the association between pretreatment LMR and survival outcomes in cervical cancer.

Methods

PubMed, Web of Science, Embase, and the Cochrane Library were searched from database inception to November 14, 2025. Studies evaluating pretreatment LMR in relation to survival outcomes in cervical cancer were included. Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled for overall survival (OS) and progression-free survival (PFS). Subgroup, sensitivity, meta-regression, and publication-bias analyses were also performed.

Results

Eighteen studies comprising 22 independent cohorts ( n = 5,127) were included. Low pretreatment LMR was associated with poorer OS in both univariable (HR = 1.94, 95% CI [1.58–2.38]) and multivariable analyses (HR = 1.66, 95% CI [1.40–1.96]), and with poorer PFS in both univariable (HR = 2.26, 95% CI [1.77–2.90]) and multivariable analyses (HR = 2.07, 95% CI [1.47–2.90]). In multivariable subgroup analyses, the adverse OS association remained evident in patients aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MonocytesUterine Cervical NeoplasmsLymphocytesHumansFemalePrognosisLymphocyte Count

Stichwörter der Autor:innen

Cervical cancerLymphocyte-to-monocyte ratioMeta-analysisPrognosisSystematic review

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Taian, Shandong Province, China.

Zitieren

APA

Zhao, G., Al Ramadhan, M. M., & Zhang, Y. (2026). Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis. PeerJ, 14, e21337. https://doi.org/10.7717/peerj.21337

Vancouver

Zhao G, Al Ramadhan MM, Zhang Y. Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis. PeerJ. 2026;14:e21337. doi:10.7717/peerj.21337

BibTeX
@article{Zhao2026,
  author = {Zhao, Guanjun and Al Ramadhan, Masmuha Marshed and Zhang, Yifang},
  title = {Prognostic value of lymphocyte to monocyte ratio for cervical cancer: a systematic review and meta-analysis},
  journal = {PeerJ},
  year = {2026},
  volume = {14},
  pages = {e21337},
  doi = {10.7717/peerj.21337}
}
Kostenlos starten →